| Model Number |
HAX01A |
| Medical Device Problem Code |
Contamination (1120)
|
| Health Effect - Clinical Code |
Unspecified Infection (1930)
|
| Date of Event |
08/14/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.(b)(4).Review of device manufacturing record history confirmed device met pre-release specifications.(b)(4).The explanted graft was not returned / retained at user facility.Therefore, direct product analysis was not possible.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2020, an gore® propaten® vascular graft (standard wall removable rings ax-bifem) was implanted due to aorta-iliac occlusive disease.On (b)(6) 2020, the graft was explanted because of a reported graft infection.The patient was diagnosed with mrsa sometime after the vascular graft was implanted.The patient was reported to be recovering well after the explant procedure.The explanted graft was discarded and a section of the graft was sent for testing at the user facility.
|
| |
|
Additional Manufacturer Narrative
|
|
H6 - code 213: review of device sterilization record history confirmed device met pre-release specifications.
|
| |
|
Additional Manufacturer Narrative
|
|
G4: pma/510(k) number was corrected.
|
| |
|
Additional Manufacturer Narrative
|
|
E1: patient's street address was added.
|
| |
|
Search Alerts/Recalls
|